Label: Information for thePatient
Zestoretic 20 mg/12.5 mg Tablets
lisinopril/hydrochlorothiazide
Read this label carefully before starting to use this medication, as it contains important information for you.
6. Contents of the pack and additional information.
Zestoretic contains two medications, lisinopril and hydrochlorothiazide. Each one reduces blood pressure through a different mechanism. Lisinopril belongs to a group of medications called ACE inhibitors. Lisinopril acts by dilating blood vessels, helping to reduce blood pressure to facilitate the heart's ability to pump blood throughout the body. Hydrochlorothiazide is a diuretic that increases the amount of urine produced by the kidneys.
Lisinopril/hydrochlorothiazide is indicated for the treatment of high blood pressure (hypertension).
Do not take lisinopril/hydrochlorothiazide if you are in any of the situations described above. If you are unsure, consult your doctor or pharmacist before taking this medication.
Warnings and precautions
Consult your doctor or pharmacist before starting to takeZestoreticif:
-Angiotensin II receptor antagonist (ARA) (also known as "sartanes" - for example, valsartan, telmisartan, irbesartan), particularly if you have kidney problems related to diabetes.
-Aliskiren
Your doctor may need to monitor your kidney function, blood pressure, and electrolyte levels in the blood (such as potassium), at regular intervals.
See also the information under the heading “Do not take Zestoretic”.
If you are unsure whether you are in any of the situations described above, consult your doctor or pharmacist before taking this medication.
Stop taking Zestoretic and seek medical attention immediatelyif:
Treatment of allergies such as insect bites
Inform your doctor if you are receiving or will be receiving a treatment to reduce the effect of an allergy to an insect bite (allergy desensitization). If you take lisinopril/hydrochlorothiazide while receiving this treatment, it may cause a severe allergic reaction.
Surgery
Inform your doctor or dentist that you are takingthis medicationbefore undergoing any surgical procedure (including dental surgery). This is because you may experience low blood pressure (hypotension) if you are given certain local or general anesthetics while taking lisinopril/hydrochlorothiazide.
Be especially careful with the initial dose ofthis medication, as it may cause a more pronounced decrease in blood pressure than what is normally achieved with continued treatment.This effect may be noticeable as dizziness or vertigo, in which case lying down may help.However, if you are concerned, consult your doctor.
Taking Zestoretic with other medications
Inform your doctor or pharmacist if you areusing, haveusedrecently or may need to use anyother medication. This is becausethis medicationmay affect how some medications work and some medications may have an effect onthis medication. Your doctor may need to adjust your dose and/or take other precautions.
Especially, inform your doctor or pharmacist if you are using any of the following medications:
If you are taking any of the following medications, the risk of developing angioedema may increase (the signs of angioedema include swelling of the face, lips, tongue, and/or throat with difficulty swallowing or breathing):
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
You should inform your doctor if you think you are (or plan to be) pregnant. Your doctor will usually advise you to stop taking lisinopril/hydrochlorothiazidebefore becoming pregnant or as soon as you find out you are pregnant and recommend that you take another medication instead ofthis medication. Lisinopril/hydrochlorothiazide is not recommended at the beginning of pregnancy, and it should not be taken if you are more than 3 months pregnant as it may cause serious harm to the baby if used after the third month of pregnancy.
Usually, lisinopril/hydrochlorothiazide should be replaced with an appropriate antihypertensive treatment before starting pregnancy. The medication should not be used during the 2nd and 3rd trimesters of pregnancy.
Usually, your doctor will advise you to stop taking lisinopril/hydrochlorothiazideas soon as you find out you are pregnant.
If you become pregnant while takingthis medication, inform and visit your doctor as soon as possible.
Breastfeeding
Inform your doctor if you are breastfeeding or plan to start breastfeeding. Hydrochlorothiazide (one of the components of the medication) is excreted in small amounts in breast milk, and at high doses, it may inhibit milk production. It is not recommended to usethis medicationin mothers during breastfeeding, and your doctor may choose another treatment for you if you want to start breastfeeding, especially if your baby is newborn or premature
Driving and operating machinery
Important information about some of the components of Zestoretic
It may cause a mild laxative effect because it contains mannitol.
Use in athletes:
This medication contains hydrochlorothiazide, which may produce a positive result in doping control tests.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Medication intake
First dose intake
Adults
Use in children and adolescents:
This medication is not recommended for use in children and adolescents as the information on safety and efficacy in this age group is limited.
If you take more Zestoretic than you should
In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone 91 562 04 20.
If you forgot to take Zestoretic
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following reactions,stop takingZestoreticand seek medical attention immediately.
Other possible side effects due to lisinopril:
Common(may affect up to 1 in 10 people):
Rare(may affect up to 1 in 100 people):
Very rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Frequency not known(cannot be estimated from available data):
Benign, malignant, and unspecified neoplasms (including cysts and polyps)
Blood and lymphatic system disorders
Metabolic and nutritional disorders
Mental and behavioral disorders
Nervous system disorders
Eye disorders
Ear and labyrinth disorders
Cardiac disorders
Vascular disorders
Respiratory, thoracic, and mediastinal disorders
Gastrointestinal disorders
Hepatic disorders
Skin and subcutaneous tissue disorders
Musculoskeletal and connective tissue disorders
Renal and urinary disorders
General disorders and administration site conditions
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
- Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Zestoretic
Appearance of the product and contents of the packaging
Zestoretic is presented in the form of round, white, uncoated tablets, with the imprint 20 12.5 on one face and a bisecting line on the other.
Holder of the marketing authorization:
Atnahs Pharma Netherlands B.V.,
Copenhagen Towers,
Ørestads Boulevard 108, 5.tv DK-2300,
København S, Denmark
Responsible for manufacturing:
AstraZeneca AB
Gärtunavägen
SE-152 57 Södertälje
Sweden
AstraZeneca Reims Production
Parc Industriel Pompelle, Chemin de Vrilly, 51100
Reims, France
ROVI Pharma Industrial Services S.A.
Vía Complutense, 140
Alcalá de Henares, 28805 Madrid
Spain
Last review date of this leaflet: March 2022
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es /
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.